Clinical Trials of Multivalent Opioid Vaccine Components
Clinical Trials of Multivalent Opioid Vaccine Components
Sponsor: National Institute on Drug Abuse
Enrolling: Male and Female Patients
Study Length: 42 Weeks
Clinic Visits: 42
IRB Number: 7712
U.S. Govt. ID: NCT04458545
Contact: Rachel Luba: 646-774-6243 /
Additional Study Information: Healthy heroin users (men and women, ages 18-59) are needed for an inpatient and outpatient study investigating medication effects at the NY State Psychiatric Institute. Earn approximately $7,250. Call the Substance Use Research Center at (646)-774-6243.
Sandra Comer, PhD
Do You Qualify?
Are you currently using heroin or other opioids? Yes No
Are you between 18 and 59 years old? Yes No
Are you pregnant or breastfeeding? Yes No
Have you ever used opioids intranasally (through your nose)? Yes No
Are you willing to receive an experimental vaccine for opioid use disorder? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Rachel Luba